Assignee
PELLFICURE PHARMACEUTICALS INC
US·5 granted patents·3 pending applications·7 citations·filing 2014–2018
Top patents by PatentIndex Score
8 records- 0187US9655868B2Treatment of prostate carcinomaPELLFICURE PHARMACEUTICALS INC·Filed 2015·Granted May 23, 2017·6 cites·17 claims
- 0264US10245240B2Treatment of prostate carcinomaPELLFICURE PHARMACEUTICALS INC·Filed 2018·Granted Apr 2, 2019·0 cites·12 claims
- 0360US9877932B2Treatment of prostate carcinomaPELLFICURE PHARMACEUTICALS INC·Filed 2017·Granted Jan 30, 2018·0 cites·25 claims
- 0459US10093620B2Compositions and methods for treatment of prostate carcinomaPELLFICURE PHARMACEUTICALS INC·Filed 2015·Granted Oct 9, 2018·1 cites·15 claims
- 0559US2018116977A1Novel treatment of prostate carcinomaPELLFICURE PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 0651US2016022606A1Novel therapy for prostate carcinomaPELLFICURE PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 0746US10577315B2Compositions and methods for treatment of prostate carcinomaPELLFICURE PHARMACEUTICALS INC·Filed 2018·Granted Mar 3, 2020·0 cites·13 claims
- 0833US2018221306A1Pharmaceutical compositions of 5-hydroxy-2-methylnaphthalene-1,4-dionePELLFICURE PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when PELLFICURE PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →